G-protein β3 subunit C825T variant and ambulatory blood pressure in essential hypertension

Hypertension

Volumn 33, Issue 4, 1999, Pages 1049-1051

  Beige, Joachim ^a   Hohenbleicher, Henriette ^a   Distler, Armin ^a   Sharma, Arya M ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Angiotensin converting enzyme; Angiotensinogen; Blood pressure monitoring, ambulatory; Genetics; Hypertension, essential; Hypertrophy, left ventricular

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; DNA; GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; AGED; GENETICS; HYPERTENSION; MIDDLE AGED; PATHOPHYSIOLOGY; REGRESSION ANALYSIS;

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; GENOTYPE; GTP-BINDING PROTEINS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS;

EID: 0032588245     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.4.1049     Document Type: Article

References (11)

1. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press; 1990: 81-100.
2. Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1994;265:2037-2048.
3. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet. 1998;18:45-48.
4. Anlauf M, Baumgart I, Franz I, Gotzen R, Krönig B, Meyer-Sabellek W, Middeke M, Schrader J, Schulte KL, Weber F. Empfehlungen der Deutschen Liga zur Bekämpfung der hohen Blutdruckes e. V.: Ambulante 24-h-Blutdruckmessung. Herz Kreislauf. 1995;27:III-VI.
5. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
6. Schmidt S, Sharma AM, Zilch O, Beige J, Walla-Friedel M, Ganten D, Distler A, Ritz E. Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. Nephrol Dial Transplant. 1995;10:1145-1148.
7. James GD, Pickering TG, Yee LS, Harshfield GA, Riva S, Laragh JH. The reproducibility of average ambulatory, home, and clinic pressures. Hypertension. 1988;11:545-549.
8. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793-801.
9. Siffert W, Rosskopf D, Moritz A, Wieland T, Kaldenberg-Stasch S, Kettler N, Hartung K, Beckmann S, Jakobs KH. Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. J Clin Invest. 1995;96:759-766.
10. Rosskopf D, Düsing R, Siffert W. Membrane sodium-proton exchange and primary hypertension. Hypertension. 1993;21:607-617.
11. Siffert W, Düsing R. Sodium-proton exchange and primary hypertension: an update. Hypertension. 1995;26:649-655.